McDermott advised DiogenX in its fundraising.DiogenX, a biotechnology company specializing in the regeneration of beta cells that produce insulin for the treatment of diabetes, has announced…
DiogenX’s EUR27.5 Million Serie A Fundraising


McDermott advised DiogenX in its fundraising.DiogenX, a biotechnology company specializing in the regeneration of beta cells that produce insulin for the treatment of diabetes, has announced…
…